Bicyclic cyclohexylamines and their use as nmda receptor antagonists
申请人:——
公开号:US20030232810A1
公开(公告)日:2003-12-18
Described are heterocycle-substituted cyclohexylamines of formula (I), and their pharmaceutically acceptable salts thereof. The compounds of formula (I) are antagonists of NMDA receptor channel complexes useful for treating cerebral vascular disorders such as, for example, cerebral ischemia, cardiac arrest, stroke, and Parkinson's disease.
1